Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
about
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsDopamine covalently modifies and functionally inactivates parkinEfficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Substantia nigra neuromelanin: structure, synthesis, and molecular behaviourCytotoxic and genotoxic potential of dopamine.Dopamine mercapturate can augment dopaminergic neurodegeneration.Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathwayDopamine thioethers: formation in brain and neurotoxicity.Echinacoside Protects against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS ProductionParkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neuronsInteraction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.The neuromelanin of human substantia nigra: physiological and pathogenic aspects.Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.Chromosomal localisation of genes coding for human and mouse liver cytosolic cysteine dioxygenase.Vulnerability of mesostriatal dopaminergic neurons in Parkinson's diseaseNeuromelanin of the human substantia nigra: an update.Protective and toxic roles of dopamine in Parkinson's disease.Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics.Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease.Kinetic evidence for the formation of a Michaelis-Menten-like complex between horseradish peroxidase compound II and di-(N-acetyl-L-tyrosine).Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.The neurotoxicity of 5-S-cysteinyldopamine is mediated by the early activation of ERK1/2 followed by the subsequent activation of ASK1/JNK1/2 pro-apoptotic signalling.Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo.Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.The pigmented life of a redhead.A comparison of the distribution of neurotransmitters in brain regions of the rat and guinea-pig using a chemiluminescent method and HPLC with electrochemical detection.Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease.Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.In vivo autoxidation of dopamine in guinea pig striatum increases with age.Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease.An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
P2860
Q21262040-5A5BF388-3515-4776-B96D-0609176CA187Q24338423-DFE45918-7D95-4B01-B690-059F4624DBBFQ27304699-A8F52B63-620F-4701-9CB0-92CE54485B47Q28365463-1ADF3D71-7037-4788-AD61-890B51BEF367Q33603762-F9C48C01-5194-4172-92E8-803FBA596A3CQ34119168-37FDDF74-3D2E-4748-9DEA-B1B775AC9068Q34339802-FB229699-800D-4D44-A6BD-109FA333D9FEQ35112545-BA3CF2C3-96FC-4946-B46F-E2DBEA8740ECQ35144118-61A58E87-B4F3-43DB-A476-E171A07AEA24Q35786982-A52D5EDD-564B-41FA-89B7-B6601F963E98Q35834043-897B02BC-EF42-4C67-BD86-C75CBA8D9DE7Q35947281-2ABC28D1-4AD6-4046-B25A-EC589314AADBQ36559682-D35912E7-CB03-42F6-8B6D-3D073E4C6BFDQ36607332-11692F54-C7AC-4563-9C78-4BC8FA1BBD08Q36822980-06F718A3-FE6F-4636-956B-92C5252B93ECQ37809751-C315E03C-51CB-46C5-8313-BCCCC970105FQ38155132-856270AB-F554-440A-9191-82A8457D12A5Q38189127-51F6B84F-5F46-40C8-B294-8C16546E264EQ39294770-8FD9F8D6-EB79-4EC9-8D17-481D6DC75EB9Q39521597-986348D7-8779-4BFA-A97B-D7511E7FC85FQ40073295-BC5C12D4-4B31-4448-8661-51E67F384F78Q40229579-74A853C3-0F53-4801-ADBA-494B7768E768Q40897573-8EFF709C-69C2-4C73-9716-9A9A48F6C44CQ41649996-B50473FE-7C68-41FC-8757-FF3368DB64F1Q41655727-6F8BE603-E0A8-46D7-8DD5-C5A6D1E67632Q42478312-9D036D87-AC6A-41D3-8A6E-ED4E2E7EDD8DQ43518858-2B6FACB9-B1F5-4BD3-852A-9772908E6707Q43580001-C1BAAE42-10DB-47B9-A269-6AFADAEFCB93Q43794661-643206F3-FE5F-44AF-B988-30BFBC3D2628Q44137393-CE97E1D8-EB35-4D80-8D65-A8D902558804Q44157297-A9ECF879-D3A5-4C16-A113-69FC4F91F3C1Q44796670-260313CA-1DA7-4F1D-ACDD-0351404370B0Q46193343-E8A39276-CE29-4B5F-A2FA-AA179AADBB8BQ46566287-2D691D10-1141-45D7-940E-26C1E53137BDQ46663033-FE132221-E847-4892-992A-57F2E434052BQ46828589-D7026B23-B3A8-45CC-A2CA-C6CAA06EC4F9Q46855135-C8A29901-C0BC-4ABF-884B-DCD2F517F9FDQ47301971-752108E7-5D53-43AC-B626-6033674BC184Q49125657-9E84CCFB-F478-4F33-A46B-CC8198939D3C
P2860
Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Occurrence and distribution of ...... ns of eight mammalian species.
@en
Occurrence and distribution of ...... ns of eight mammalian species.
@nl
type
label
Occurrence and distribution of ...... ns of eight mammalian species.
@en
Occurrence and distribution of ...... ns of eight mammalian species.
@nl
prefLabel
Occurrence and distribution of ...... ns of eight mammalian species.
@en
Occurrence and distribution of ...... ns of eight mammalian species.
@nl
P2093
P1433
P1476
Occurrence and distribution of ...... ns of eight mammalian species.
@en
P2093
Carlsson A
Fornstedt B
Rosengren E
P304
P356
10.1016/0028-3908(86)90242-X
P577
1986-04-01T00:00:00Z